Mesothelioma Cancer Centers
Huntsman Cancer Institute
Doctors Affiliated with this Treatment Facility
The Huntsman Cancer Institute, sometimes called HCI, is a leader of cancer and mesothelioma research, with over 135 doctors actively involved in four research programs around basic, translational and clinical cancer research. Huntsman Cancer Institute is a National Cancer Institute-designated Cancer Center located in Salt Lake City, Utah. The University of Utah’s Health Care System was formed in 1905 with the introduction of two medical courses to the school’s biology department. By 1912, a two-year medical program was implemented, and became a fully-accredited degree-granting program in 1944. The first cancer research building opened in 1951 as part of the health sciences campus, and the University of Utah Medical Center was completed in 1965. The institute takes a collaborative approach to research, as scientists and doctors work together to investigate the genetics of cancer, as well as develop novel treatments.
Mesothelioma specialists at the Huntsman Cancer Institute are versed in a variety of first-line treatments for the cancer, including surgery, chemotherapy, radiation and targeted therapies. Additionally, the HCI is leading over 200 clinical trials at any given time, which gives eligible patients the opportunity to receive promising emerging treatments including immunotherapy and gene therapy.
In addition to mesothelioma treatment, the Huntsman Cancer Institute offers financial advocates, supportive oncology and survivorship programs, support groups, religious services and spiritual care, as well as patient and family lodging. The cancer center hosts more than 50,000 cancer patients each year in need of extended stays for treatment.
- Car T-cell therapy
- Hyperthermic intraperitoneal chemotherapy (HIPEC)
- Palliative care
- Stereotactic radiosurgery
- National Cancer Institute (NCI) Comprehensive Cancer Center Designation
- U.S. News & World Report Best Hospital
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette